More Noxopharm Ltd. news
Noxopharm Ltd.ASX: NOX

1st Patient treated in Lupin Study at St Vincents Hospital

Nov 15, 2017 at 10:13 PM EST · Issued by Noxopharm Ltd.

Filed with ASX · Nov 15, 2017 at 10:13 PM EST · 3 pages · English

On 6ix: 6ix.com/news/1st-patient-treated-in-lupin-study-at-st-vincents-hospital

Noxopharm Ltd. on 6ix

Earlier from Noxopharm

  • UNSW collaboration confirms drug designed for stroke victimsNov 2, 2017
  • Australian NOX66 - Radiotherapy Study OpensSep 26, 2017
  • Establishment of Nyrada Inc.Sep 24, 2017
  • Positive Clinical Outcomes for NOX66 at ESMO ConferenceSep 11, 2017
  • Important Brain Cancer Findings for NOX66 ProgramAug 29, 2017

Later from Noxopharm

  • Promising Interim Clinical Data for NOX66Nov 19, 2017
  • Clarification of Incorrect InformationNov 23, 2017
  • NYX-104 delivers Key Proof-of-Concept in Stroke Animal ModelNov 28, 2017
  • Nyrada Inc Opens Capital Raise - Memorandum ReleasedNov 30, 2017
  • EOY Guidance on 2018 NOX66 Clinical Development StrategyDec 21, 2017
All Noxopharm news releases↗

Follow Noxopharm into a list and get an email when it puts out news.

Follow Noxopharm
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer